Displaying 141–150 of 152 news results
Jan 18, 2018
The Assistance Fund Opens New Program for Inherited Retinal Diseases
The Assistance Fund, an independent charitable patient assistance foundation that helps patients and families facing high medical out-of-pocket costs, today launched a new program that offers financial support for individuals with inherited retinal diseases.
Jan 9, 2018
A Retinal Research Nonprofit Paves the Way for Commercializing Gene Therapies
AN EMERGING, vision-restoring gene therapy for a devastating retinal disease is poised for Food and Drug Administration (FDA) approval. If it gets the regulatory nod, it will be the first gene therapy to receive FDA approval for the eye or an inherited condition.
Oct 12, 2017
FDA Advisory Committee Unanimously Recommends Approval of Investigational LUXTURNA™ (voretigene neparvovec) for Patients with Biallelic RPE65-mediated Inherited Retinal Disease
Investigational LUXTURNA has the potential to be both the first pharmacologic treatment for an inherited retinal disease (IRD) and the first gene therapy for a genetic disease in the United States
First adeno-associated viral (AAV) vector investigational candidate to reach this stage of FDA review
Investigational LUXTURNA clinical program includes up to four years of efficacy data, with observation ongoing
Apr 13, 2016
Foundation Fighting Blindness Announces Leadership Succession Plan After 45 Year Legacy
David Brint has been elected Chairman, effective July 1, 2016. Brint succeeds co-founder and current Chairman, Gordon Gund, who will remain a member of the Board of Directors and will continue to be actively involved in the Foundation’s Research Oversight Committee
Oct 1, 2015
The Challenge Continues: FFB Chairman Gordon Gund is Interviewed on CNBC
In a recent interview with CNBC’ s Brian Sullivan, during a tech-investor conference in Nantucket, Gordon explained why this is such a crucial time in retinal-research history.
Jan 14, 2014
Vision Improvements Reported in Choroideremia Gene Therapy Clinical Trial
Five of six participants in the initial study group have sustained vision improvements in their treated eyes in dim settings.
Dec 12, 2013
FFB Chairman, Gordon Gund, Interviewed on Forbes.com
The Foundation’s chairman and co-founder, Gordon Gund is interviewed on Forbes.com
Jul 9, 2013
Foundation Fighting Blindness Presents Llura Liggett Gund Award To University Of Florida Researcher Targeting Vision-Saving Treatments and Cures
William W. Hauswirth, Ph.D., Honored for Lifetime Scientific Achievement at VISIONS 2013
Mar 2, 2012
Foundation Commits $2 Million to Development of a Cross-Cutting Drug Treatment
MitoChem Therapeutics has identified three compounds that appear to boost mitochondrial function and, thus, show potential for slowing vision loss caused by a variety of retinal degenerations.
Apr 4, 2011
Researchers Take another Critical Step toward Using Skin Cells to Treat Retinal Disease
A research team funded by the Foundation Fighting Blindness used an innovative repair technique to correct the disease-causing genetic defect in stem cells derived from a person’s skin — stem cells that hold the potential to treat their retinal degenerative condition.